I am a board certified hematologist specializing in bone marrow transplantation for leukemia, myelodysplastic syndromes, lymphoma, and other bone marrow disorders. I work in a collaborative fashion with other members of our team to provide comprehensive cancer care at Memorial Sloan Kettering Cancer Center. My research focuses on the role of Natural Killer (NK) cells in outcomes after transplantation. NK cells are white blood cells that have anti-tumor and anti-infection properties. My goal is to improve the transplantation process for patients via understanding and optimizing NK cell behavior. My clinical interests also include improving transplantation methods for patients without a matched sibling donor.
- Clinical Expertise: Autologous and allogeneic bone marrow transplantation; alternative donor transplantation
- Languages Spoken: English
- Education: Eastern Virginia Medical School
- Residencies: Wake Forest University Medical Center (North Carolina)
- Fellowships: National Cancer Institute (Maryland); National Heart, Lung and Blood Institute (Maryland)
- Board Certifications: Internal Medicine; Hematology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more